LUMIGAN (bimatoprost) Coupons, Discounts & Cost
Lumigan (bimatoprost) Coupons, Discounts & Cost
Lumigan eye drops are used in the treatment of glaucoma (persistent elevation of intraocular pressure) and ocular pressure. One way to save money on the Lumigan retail cost regardless of income and insurance status is to use Lumigan coupons or discount cards from RXCoupons. Use this Bimatoprost coupon at this online pharmacy and receive up to 75% off the sale price.
Lumigan pharmacological properties
Lumigan eye drops are used in the treatment of glaucoma (persistent elevation of intraocular pressure) and ocular pressure. The main active ingredient is bimatoprost. Bimatoprost is a synthetic prostaglandin used to reduce intraocular pressure in open-angle glaucoma or ocular hypertension. Bimatoprost is also used as a cosmetic product that accelerates the growth of eyelashes.
Lumigan ophthalmic solution is indicated for the conservative treatment of high intraocular pressure in patients with ocular hypertension and open-angle glaucoma. Lumigan drops help normalize the fluid outflow. The drug is recommended for long-term continuous use.
Bimatoprost penetrates well through the cornea. The drug starts working within 4 hours. The effects of Lumigan last for about 24 hours.
Lumigan recommendations for use
According to the instructions, you need to wash your hands before the procedure, and then instill 1 drop in the eye (1 time per day). If you wear lenses, simply remove lenses before you decide to use the drug.
Instill 1 drop in the affected eye once a day. After instillation, you need to lie down for a few minutes with your eyes closed.
Higher doses can reduce the therapeutic effect of the drug. The standard scheme is no more than one drop per day to the affected eye. If the dose was missed, the basic scheme should be continued without changes. At the same time, it is necessary to carefully monitor the level of IOP when taking bimatoprost with other prostaglandin analogues.
What are the contraindications for Lumigan?
The main contraindication is hypersensitivity to bimatoprost. The drug is not recommended for use during pregnancy.
Possible side effects of Lumigan
The most common side effect is redness of the conjunctiva. Other common side effects include pruritus, burning, pain, eye irritation, blurred vision, pigmentation of periocular area, blepharitis, cataract, periorbital erythema, photophobia, allergic conjunctivitis, asthenopia, increased pigmentation of the iris, conjunctival edema.
Systemic side effects: upper respiratory tract infection. Approximately 1-5% of patients may complain of headache, asthenic conditions.
Precautions and warnings
Bimatoprost often causes increased amounts of pigment in the iris, eyelids and eyelashes (depending on the duration of treatment).
The drug is used with caution in patients with active intraocular inflammation (e.g., uveitis, iritis). In this connection, careful monitoring is needed in patients using this drug, especially in those with viral eye disease (e.g., herpes simplex eye infection).
Bimatoprost may contribute to the development of macular edema (in rare cases). For this reason, it is not recommended for use in patients with certain pathologies (aphakia, diabetic retinopathy).
Lumigan must be used with caution in patients with renal and hepatic insufficiency.
The effects of bimatoprost have not been studied in patients with impaired respiratory function. However, the therapy may lead to possible worsening of bronchial asthma, dyspnea and chronic obstructive pulmonary disease.
The effects of bimatoprost have not been studied in patients with progressive heart failure, but there were few reports about the development of bradycardia or hypotension during Lumigan therapy. Therefore, it is recommended to use Lumigan with caution in patients with decreased heart rate and low blood pressure.
It is necessary to monitor the state of the cornea during long-term treatment (due to the risk of toxic keratopathy, especially in patients who use contact lenses).
There is no data on the effect of bimatoprost on fertility in humans. The drug has no carcinogenic and mutagenic effects.